Improving the Efficacy of Anti-Nicotine Immunotherapy (PETNic002)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Wake Forest University
Novartis
Information provided by (Responsible Party):
Alexey Mukhin, Duke University Medical Center
ClinicalTrials.gov Identifier:
NCT01280968
First received: November 16, 2010
Last updated: November 13, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2013
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)